WeLeader Biomedical Co., Ltd.

Research WeLeader Biomedical Co., Ltd. (7713.TWO) on Bullrun: market cap TWD 3.32B, P/E 14.5, dividend yield 5.8%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is TWD 3.32B; P/E is 14.5; dividend yield is 5.8%.

Peer valuation comparison

Latest P/E is 14.46x versus a Healthcare sector median of 21.8x (33.7% below).

Latest dividend yield is 5.81% versus a Healthcare sector median of 2.4% (142.1% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18TWD 3.32B14.55.6%4.1

Dividend history

Latest trailing dividend snapshot: annual dividend/share 4.1 TWD, yield 5.8%.

About WeLeader Biomedical Co., Ltd.

WeLeader Biomedical Co., Ltd. operates as an agent and distributor of in vitro diagnostic products. It offers a range of medical testing systems, such as serum biochemistry integration platform, clinical care, and medical information integration system.

Related stock research

Taiwan stocks Taiwan Healthcare stocks A-Z stock index

Other Healthcare stocks

Apex Biotechnology Corp. (1733.TW) Health & Life Co., Ltd. (1781.TWO) Hi-Clearance Inc. (1788.TWO) Radiant Innovation Inc. (3373.TWO) Wellell Inc. (4106.TW) Rossmax International Ltd. (4121.TWO) United Orthopedic Corporation (4129.TWO) Dynamic Medical Technologies Inc. (4138.TWO) OK Biotech Co., Ltd. (4155.TW) Bioptik Technology Incorporation (4161.TWO) EPS Bio Technology Corp. (4183.TWO) AmCad BioMed Corporation (4188.TWO)

Frequently asked questions

What is WeLeader Biomedical Co., Ltd.'s market cap?

WeLeader Biomedical Co., Ltd.'s market capitalization is TWD 3.32B.

What is WeLeader Biomedical Co., Ltd.'s P/E ratio?

WeLeader Biomedical Co., Ltd.'s price-to-earnings (P/E) ratio is 14.5.

Does WeLeader Biomedical Co., Ltd. pay a dividend?

WeLeader Biomedical Co., Ltd. has a dividend yield of 5.8%.

What does WeLeader Biomedical Co., Ltd. do?

WeLeader Biomedical Co., Ltd. operates as an agent and distributor of in vitro diagnostic products. It offers a range of medical testing systems, such as serum biochemistry integration platform, clinical care, and medical information integration system.